Old Web
English
Sign In
Acemap
>
authorDetail
>
Margarita Salcedo-Magguilli
Margarita Salcedo-Magguilli
Medicine
Clinical trial
in patient
Septic shock
Placebo
3
Papers
11
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
sTREM-1 is a specific biomarker of TREM-1 pathway activation
2021
Cellular & Molecular Immunology
Lucie Jolly
Kevin Carrasco
Margarita Salcedo-Magguilli
Jean-Jacques Garaud
Simon Lambden
Tom van der Poll
Alexandre Mebazaa
Pierre-François Laterre
Sébastien Gibot
Amir Boufenzer
Marc Derive
Show All
Source
Cite
Save
Citations (0)
Rationale and protocol for the efficacy, safety and tolerability of nangibotide in patients with septic shock (ASTONISH) phase IIb randomised controlled trial.
2021
BMJ Open
Bruno François
Simon Lambden
Sébastien Gibot
Marc Derive
Aurélie Olivier
Valérie Cuvier
Stephan Witte
Jean-Marie Grouin
Jean-Jacques Garaud
Margarita Salcedo-Magguilli
Mitchell M. Levy
Pierre-François Laterre
Show All
Source
Cite
Save
Citations (0)
Nangibotide in patients with septic shock: a Phase 2a randomized controlled clinical trial.
2020
Intensive Care Medicine
Bruno François
Xavier Wittebole
Ricard Ferrer
Jean-Paul Mira
Thierry Dugernier
Sébastien Gibot
Marc Derive
Aurélie Olivier
Valérie Cuvier
Stephan Witte
Peter Pickkers
François Vandenhende
Jean-Jacques Garaud
Miguel Sanchez
Margarita Salcedo-Magguilli
Pierre-François Laterre
Show All
Source
Cite
Save
Citations (11)
1